UCLA Medical Center Obstetrics and Gynecology

Topics

• Pelvic floor disorders treatments 373
• Ovarian cancer diagnosis and treatment 274
• Endometrial and Cervical Cancer Treatments 193
• Ovarian function and disorders 178
• Urinary Bladder and Prostate Research 170
• Prostate Cancer Diagnosis and Treatment 168
• Reproductive Health and Contraception 134
• Preterm Birth and Chorioamnionitis 125
• Maternal and fetal healthcare 117
• Pregnancy and preeclampsia studies 112
• Reproductive Biology and Fertility 111
• Maternal and Perinatal Health Interventions 106

Most cited

1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

   The New England journal of medicine · 2023 · 703 citations · Dana Chase

2. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Ritu Salani

3. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 914 citations · Beth Karlan

4. Nosology of genetic skeletal disorders: 2023 revision.

   American journal of medical genetics. Part A · 2023 · 303 citations · Deborah Krakow

5. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Ritu Salani

6. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Gottfried E. Konecny